Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$3.96 USD
+0.03 (0.76%)
Updated Sep 23, 2024 11:21 AM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.93 |
Last EPS Surprise | 26.19% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.56 |
Next Year | -2.29 |
EPS (TTM) | -4.43 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.50M | 20.00M | 10.93M | 1.20M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 0.50M | 20.00M | 21.20M | 1.20M |
Low Estimate | 0.50M | 20.00M | 0.65M | 1.20M |
Year ago Sales | 0.01M | 0.83M | 2.05M | 10.93M |
Year over Year Growth Est. | 4,900.00% | 2,309.64% | 432.67% | -89.02% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.32 | -2.56 | -2.29 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.46 | -0.39 | -3.27 | -1.80 |
High Estimate | -0.18 | 0.22 | -0.57 | -1.12 |
Low Estimate | -0.86 | -0.80 | -3.88 | -3.94 |
Year ago EPS | -1.04 | -1.17 | -4.18 | -2.56 |
Year over Year Growth Est. | 51.92% | 72.65% | 38.76% | 10.77% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 2 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.32 | -2.56 | -2.29 |
7 Days Ago | -0.50 | -0.32 | -2.56 | -2.29 |
30 Days Ago | -0.50 | -0.32 | -2.56 | -2.29 |
60 Days Ago | -0.42 | -0.78 | -3.15 | -1.55 |
90 Days Ago | -0.42 | -0.78 | -3.15 | -1.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.32 | -2.56 | -2.29 |
Zacks Consensus Estimate | -0.50 | -0.32 | -2.56 | -2.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.93 | -1.29 | -1.17 | -1.04 | NA |
Estimate | -1.26 | -1.21 | -1.18 | -1.10 | NA |
Difference | 0.33 | -0.08 | 0.01 | 0.06 | 0.08 |
Surprise | 26.19% | -6.61% | 0.85% | 5.45% | 6.47% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more